Allen Frances

Allen Frances is a prominent American psychiatrist known for his work on the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) and his critiques of the American Psychiatric Association (APA) and the DSM-5. He has been a vocal critic of the pharmaceutical industry and its influence on psychiatry, often citing the work of Marcia Angell and the New England Journal of Medicine. Frances has also been involved in various National Institute of Mental Health (NIMH) initiatives and has collaborated with Robert Spitzer and Samuel Guze on several projects.

● Early life and education

Allen Frances was born in New York City and grew up in a family of Columbia University and New York University (NYU) alumni. He attended Phillips Exeter Academy and later graduated from Columbia University, where he studied pre-med and was influenced by the work of Eric Kandel and Robert Sapolsky. Frances then went on to attend the New York University School of Medicine (NYU School of Medicine), where he earned his medical degree and was trained by Karl Menninger and Frieda Fromm-Reichmann. During his residency at Columbia University Irving Medical Center, Frances worked with Erik Erikson and Heinz Kohut, and later became a fellow at the National Institute of Mental Health (NIMH) under the guidance of David Kupfer and Gerald Klerman.

● Career

Frances began his career as a psychiatrist at Duke University School of Medicine, where he worked with Bernard Carroll and John Feighner on various clinical trials and research studies. He later became the chair of the Department of Psychiatry at Duke University Hospital and was involved in the development of the DSM-IV with Robert Spitzer and Samuel Guze. Frances has also held positions at Stanford University School of Medicine and University of California, San Francisco (UCSF), where he collaborated with Irving Gottesman and Kay Redfield Jamison on genetic studies and twin studies. Throughout his career, Frances has been recognized for his contributions to psychiatry with awards from the American Psychiatric Association (APA) and the National Alliance on Mental Illness (NAMI), and has been elected as a fellow of the American College of Psychiatrists and the American Academy of Arts and Sciences.

● Work and publications

Frances has published numerous articles and books on psychiatry and mental health, including Saving Normal: An Insider's Revolt Against Out-of-Control Psychiatric Diagnosis, DSM-5, Big Pharma, and the Medicalization of Ordinary Life and Essentials of Psychiatric Diagnosis: Responding to the Challenge of DSM-5. He has also written for The New York Times, The Huffington Post, and Psychology Today, often discussing topics such as attention deficit hyperactivity disorder (ADHD), bipolar disorder, and post-traumatic stress disorder (PTSD) with Bessel van der Kolk and Judith Herman. Frances has been a vocal critic of the DSM-5 and has argued that it has led to overdiagnosis and overtreatment of mental health conditions, citing the work of Thomas Insel and the National Institute of Mental Health (NIMH).

● Critique of DSM-5

Frances has been a leading critic of the DSM-5, arguing that it has introduced new and unnecessary diagnostic categories such as disruptive mood dysregulation disorder (DMDD) and binge eating disorder (BED). He has also criticized the American Psychiatric Association (APA) for its handling of the DSM-5 development process, citing the influence of the pharmaceutical industry and the lack of transparency and accountability. Frances has worked with David Elkins and the Society for Humanistic Psychology to promote a more humanistic and person-centered approach to psychiatry, and has argued that the DSM-5 should be revised to include more dimensional assessments and personalized treatment plans, as advocated by Marsha Linehan and the Dialectical Behavior Therapy (DBT) community.

● Personal life and views

Frances is a vocal advocate for mental health reform and has argued that the mental health system should prioritize prevention and early intervention over pharmacological treatments. He has also been critical of the health insurance industry and its influence on mental health care, citing the work of Uwe Reinhardt and the Princeton University Center for Health and Wellbeing. Frances has been involved in various advocacy groups, including the National Alliance on Mental Illness (NAMI) and the Mental Health America (MHA), and has worked with Patrick Kennedy and the One Mind for Research initiative to promote brain research and neuroscience education. Throughout his career, Frances has been recognized for his contributions to psychiatry and mental health with awards from the American Psychiatric Association (APA) and the National Institute of Mental Health (NIMH), and has been elected as a fellow of the American College of Psychiatrists and the American Academy of Arts and Sciences. Category:American psychiatrists